| dc.identifier.citation | Abata, Q. (2014). Ilmu penyakit Dalam edisi lengkap. Al Furqon Penerbit: madiun. Abubakar, A., Chedi, B., Mohammed, K., & Haque, M. (2015). Drug interaction and its implication in clinical practice and personalized medicine. National Journal of Physiology, Pharmacy and Pharmacology, 5(5), 343. https://doi.org/10.5455/njppp.2015.5.2005201557 Agus A. M , Nyoman M. K , & Muliani. (2021). Prevalensi Hipertensi Pada Penderita Penyakit Jantung Koroner (PJK) Di RSUP sanglah Denpasar Maret- September 2019 Fakultas Kedokteran Universitas Udayana. ISSN: 2597-8012, Jurnal Medika Udayana, Vol.10 No.4.April, 2021 Agustin, O. A., & Fitrianingsih, F. (2020). Kajian Interaksi Obat Berdasarkan Kategori Signifikansi Klinis Terhadap Pola Peresepan Pasien Rawat Jalan Di Apotek X Jambi. Electronic Journal Scientific of Environmental Health And Disease, 1(1). Al Fajar. (2015). Hubungan Aktivitas Fisik dan Kejadian Penyakit Jantung Koroner di Indonesia : Analisis Data Riskesdas 2013. Jakarta : Fakultas Kedokteran dan Ilmu Kesehatan Universitas Islam Negeri Syarif Hidayatullah Jakarta. Skripsi tidak dipublikasikan. AlRuthia, Y., Alkofide, H., Alosaimi, F. D., Sales, I., Alnasser, A., Aldahash, A., Almutairi, L., AlHusayni, M. M., & Alanazi, M. A. (2019). Drug-drug interactions and pharmacists’ interventions among psychiatric patients in outpatient clinics of a teaching hospital in Saudi Arabia. Saudi Pharmaceutical Journal, 27(6), 798–802. https://doi.org/10.1016/j.jsps.2019.05.001 Alvim, M. M., Silva, L. A. da, Leite, I. C. G., & Silvério, M. S. (2015). Adverse events caused by potential drug-drug interactions in an intensive care unit of a teaching hospital. Revista Brasileira de Terapia Intensiva, 27(4). https://doi.org/10.5935/0103-507X.20150060 Andriani, Y. (2017). Profil Pasien Pengguna Obat Jantung Koroner Rawat Inap Di RSUD Sultan Syarif Mohammad Alkadrie Pontianak. Jurnal Mahasiswa Farmasi Fakultas Kedokteran Untan, 4(1). Barton, M. (2013). Cholesterol and atherosclerosis. Current Opinion in Lipidology, 24(3), 214–220. https://doi.org/10.1097/MOL.0b013e3283613a94 Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., ... & Muntner, P. (2018). Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation, 137(12), e67-e492. Bestari, I. P., Rizal, F., & Lubis, S. Y. (2020). Hubungan Pola Makan terhadap Kejadian Dispepsia di RSUD Meuraxa Kota Banda Aceh. Kandidat: Jurnal Riset dan Inovasi Pendidikan, 2(1), 6-73.. Beyer, C., Wildauer, M., Feuchtner, G., Friedrich, G., Hintringer, F., Stühlinger, M., & Plank, F. (2020). Relationship of Anticoagulant Therapies on Coronary Plaque Progression. JACC: Cardiovascular Imaging, 13(1), 169–170. https://doi.org/10.1016/j.jcmg.2019.07.021 Busa, G., Burlina, A., Damuzzo, V., Chiumente, M., & Palozzo, A. C. (2018). Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs. Journal of Pharmacy Practice, 31(1), 58–65. https://doi.org/10.1177/0897190017699138 Cantudo-Cuenca, M. D., Gutiérrez-Pizarraya, A., Pinilla-Fernández, A., Contreras-Macías, E., Fernández Fuertes, M., Lao Domínguez, F. A., Rincón, P., Pineda, J. A., Macías, J., & Morillo-Verdugo, R. (2021). Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain. Scientific Reports, 11(1), 12414. https://doi.org/10.1038/s41598-021-91953-2 Cascorbi, I. (2012). Drug Interactions. Deutsches Ärzteblatt International. https://doi.org/10.3238/arztebl.2012.0546 Chang, S.-M., Lu, I.-C., Chen, Y.-C., Hsuan, C.-F., Lin, Y.-J., & Chuang, H.-Y. (2021). Behavioral Factors Associated with Medication Nonadherence in Patients with Hypertension. International Journal of Environmental Research and Public Health, 18(18), 9614. https://doi.org/10.3390/ijerph18189614 Choi, Y. H., Lee, I. H., Yang, M., Cho, Y. S., Jo, Y. H., Bae, H. J., Kim, Y. S., & Park, J. D. (2021). Clinical significance of potential drug–drug interactions in a pediatric intensive care unit: A single-center retrospective study. PLOS ONE, 16(2), e0246754. https://doi.org/10.1371/journal.pone.0246754 Cooper-DeHoff, R. M., Chang, S.-W., & Pepine, C. J. (2013). Calcium antagonists in the treatment of coronary artery disease. Current Opinion in Pharmacology, 13(2), 301–308. https://doi.org/10.1016/j.coph.2013.01.008 Das, S., Behera, S., Xavier, A., Dharanipragada, S., & Selvarajan, S. (2019). Are drug-drug interactions a real clinical concern? Perspectives in Clinical Research, 10(2), 62. https://doi.org/10.4103/picr.PICR_55_18 Derajat, H., Gagal, K., & Kronik, G. (2018). Hubungan Derajat Keparahan Gagal Ginjal Kronik Dengan Kejadian Penyakit Jantung Koroner. Diponegoro Medical Journal (Jurnal Kedokteran Diponegoro), 7(2), 472–484. Dézsi, C. A., & Szentes, V. (2017). The Real Role of β-Blockers in Daily Cardiovascular Therapy. American Journal of Cardiovascular Drugs, 17(5), 361–373. https://doi.org/10.1007/s40256-017-0221-8 Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018). Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular Diabetology, 17(1), 83. https://doi.org/10.1186/s12933-018-0728-6 Elfi, E. F. (2015). Sindrom Koroner Akut dengan Komplikasi Udem Paru Akut dan Henti Jantung. Jurnal Kesehatan Andalas, 4(2), 613–617. https://doi.org/10.25077/jka.v4i2.309 Fahri, I., Dianiati, & Yunus, F. (2009). Efek Peradangan Sistemik Pada PPOK Terhadap Sistem Kardiovaskular. Respirologi Indonesia, V. 29. N 3(January), 1–13. Gitawati, R. 2008, Interaksi obat dan beberapa implikasinya. Media Penelitian dan Pengembangan Kesehatan, 18(4 Des) Media Litbang Kesehatan vol.18, no. 4, pp.177-178. Hajar, R. (2017). Risk factors for coronary artery disease: Historical perspectives. Heart Views, 18(3), 109. https://doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_106_17 Handayani, F. W., Muhtadi, A., Farmasi, F., Padjadjaran, U., Dara, T., Manis, K., & Aktif, S. (2013). Farmaka Farmaka. Farmaka Suplemen, 14(1), 1–15. Haryanti, I. A. P., & Berawi, K. N. (2015). Terapi Konservatif dan Terapi Pengganti Ginjal sebagai Penatalaksanaan pada Gagal Ginjal Kronik. Jurnal Majority, 4(7), 49-54. Iskandar, I., Hadi, A., & Alfridsyah, A. (2017). Faktor risiko terjadinya penyakit jantung koroner pada pasien Rumah Sakit Umum Meuraxa Banda Aceh. Action: Aceh Nutrition Journal, 2(1), 32-42. Kalangi, C. S., Jim, E. L., & Joseph, V. F. (2016). Gambaran aritmia pada pasien penyakit jantung koroner di RSUP Prof. Dr. RD Kandou Manado periode 1 Januari 2015–31 Desember 2015. e-CliniC, 4(2). Karyatin, K. (2019). Faktor-Faktor yang Berhubungan dengan Kejadian Penyakit Jantung Koroner. Jurnal Ilmiah Kesehatan, 11(1), 37-43. Khan, M. S., Fonarow, G. C., Ahmed, A., Greene, S. J., Vaduganathan, M., Khan, H., Marti, C., Gheorghiade, M., & Butler, J. (2017). Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure. Circulation: Heart Failure, 10(8). https://doi.org/10.1161/CIRCHEARTFAILURE.117.003956 Komala, R. D., & Nellyaningsih, N. (2017). Tinjauan Implementasi Personal Selling Pada Pt. Astra International Daihatsu Astra Biz Center Bandung Pada Tahun 2017. Proceedings of Applied Science, 3(2). Kuncoro, B., & Yanti, Y. (2019). Evaluasi Interaksi Obat Jantung Koroner Pada Pasien Rawat Inap Di Rumah Sakit Umum Kabupaten Tangerang 2017. Jurnal Farmagazine, 6(1), 38-46. Kureshi, F., Shafiq, A., Arnold, S. v., Gosch, K., Breeding, T., Kumar, A. S., Jones, P. G., & Spertus, J. A. (2017). The prevalence and management of angina among patients with chronic coronary artery disease across US outpatient cardiology practices: insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study. Clinical Cardiology, 40(1), 6–10. https://doi.org/10.1002/clc.22628 Kurniawati, F., Yasin, N. M., Dina, A., Atana, S., & Hakim, S. N. (2021). Kajian Adverse Drug Reactions Terkait Interaksi Obat di Bangsal Rawat Inap Rumah Sakit Akademik UGM. Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), 10(4). https://doi.org/10.22146/jmpf.60228 Lala, A., & Desai, A. S. (2014). The Role of Coronary Artery Disease in Heart Failure. Heart Failure Clinics, 10(2), 353–365. https://doi.org/10.1016/j.hfc.2013.10.002 Leon, B. M. (2015). Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World Journal of Diabetes, 6(13), 1246. https://doi.org/10.4239/wjd.v6.i13.1246 Lestari, R. D., Dewi, R., & Sanuddin, M. (2020). Evaluasi Penggunaan Obat Pada Pasien Penyakit Jantung Koroner Di Instalasi Rawat Inap RSUD Raden Mattaher Jambi. Journal of Healthcare Technology and Medicine, 6(1), 54-61. Lim, S. Y. (2013). Role of Statins in Coronary Artery Disease. Chonnam Medical Journal, 49(1), 1. https://doi.org/10.4068/cmj.2013.49.1.1 Mackenzie, I. S., Coughtrie, M. W. H., MacDonald, T. M., & Wei, L. (2010). Antiplatelet drug interactions. Journal of Internal Medicine, 268(6), 516–529. https://doi.org/10.1111/j.1365-2796.2010.02299.x Madsen, K. S., Kähler, P., Kähler, L. K., Madsbad, S., Metzendorf, M.-I., Richter, B., & Hemmingsen, B. (2016). Metformin and sulphonylurea (second- or third-generation) combination therapy for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD012368 Malakar, A. Kr., Choudhury, D., Halder, B., Paul, P., Uddin, A., & Chakraborty, S. (2019). A review on coronary artery disease, its risk factors, and therapeutics. Journal of Cellular Physiology, 234(10), 16812–16823. https://doi.org/10.1002/jcp.28350 Morales-Ríos, O., Jasso-Gutiérrez, L., Reyes-López, A., Garduño-Espinosa, J., & Muñoz-Hernández, O. (2018). Potential drug-drug interactions and their risk factors in pediatric patients admitted to the emergency department of a tertiary care hospital in Mexico. PLOS ONE, 13(1), e0190882. https://doi.org/10.1371/journal.pone.0190882 Munandar, A. A. (2019). Asuhan Keperawatan Pada Pasien Dewasa Penderita Gagal Jantung Dengan Masalah Penurunan Curah Jantung Di Ruang Aster RSUD dr. Harjono Ponorogo (Doctoral dissertation, Universitas Muhammadiyah Ponorogo). Naga, S., 2012. Buku panduan lengkap Ilmu penyakit dalam. Jakarta: Diva Press hal : 143 Niu, J., Straubinger, R. M., & Mager, D. E. (2019). Pharmacodynamic Drug–Drug Interactions. Clinical Pharmacology & Therapeutics, 105(6), 1395–1406. https://doi.org/10.1002/cpt.1434 Nuryati, 2017, Farmakologi, Bahan Ajar Rekam medis dan Informasi Kesehatan (RMIK), Pusat Pendidikan Sumber Daya Manusia Kesehatan, Badan Pengembangan dan pemberdayaan Sumber Daya Manusia Kesehatan, Kementerian Kesehatan Republik Indonesia, Edisi 2017. Palleria, C., di Paolo, A., Giofrè, C., Caglioti, C., Leuzzi, G., Siniscalchi, A., de Sarro, G., & Gallelli, L. (2013). Pharmacokinetic drug-drug interaction and their implication in clinical management. Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences, 18(7), 601–610. Perera, S., Aslam, A., Stehli, J., Kaye, D., Layland, J., Nicholls, S. J., Cameron, J., & Zaman, S. (2021). Gender Differences in Healthy Lifestyle Adherence Following Percutaneous Coronary Intervention for Coronary Artery Disease. Heart, Lung and Circulation, 30(1), e37–e40. https://doi.org/10.1016/j.hlc.2020.06.024 Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Pedoman Tatalaksana Sindrom Koroner Akut. Edisi IV. Jakarta : PERKI. 2018. Purvey, M., & Allen, G. (2017). Managing acute pulmonary oedema. Australian Prescriber, 40(2), 59–63. https://doi.org/10.18773/austprescr.2017.013 Qavi, A. H., Kamal, R., & Schrier, R. W. (2015). Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome. International Journal of Nephrology, 2015, 1–9. https://doi.org/10.1155/2015/975934 Rahmawati, D. U., & Mutmainah, N. (2021). Kajian Interaksi Obat Potensial Pada Pasien Penyakit Jantung Koroner Rawat Inap di RSUD Moewardi Tahun 2018. Proceeding of The Urecol, 417-428. Rampengan, S. H. (2014). Edema paru kardiogenik akut. Jurnal Biomedik: JBM, 6(3). Rasool, M. F., Rehman, A. ur, Imran, I., Abbas, S., Shah, S., Abbas, G., Khan, I., Shakeel, S., Ahmad Hassali, M. A., & Hayat, K. (2020). Risk Factors Associated With Medication Errors Among Patients Suffering From Chronic Disorders. Frontiers in Public Health, 8. https://doi.org/10.3389/fpubh.2020.531038 Rendayu, I., & Sukohar, A. (2018). Pemilihan Jenis Obat Antiaritmia yang Tepat untuk Penyembuhan Pasien Aritmia. Jurnal Majority, 7(3), 249-254. Riset Kesehatan Dasar. (2018). Badan Penelitian dan Pengembangan Kesehatan Kementrian RI tahun 2018. Rodgers, J. L., Jones, J., Bolleddu, S. I., Vanthenapalli, S., Rodgers, L. E., Shah, K., Karia, K., & Panguluri, S. K. (2019). Cardiovascular Risks Associated with Gender and Aging. Journal of Cardiovascular Development and Disease, 6(2), 19. https://doi.org/10.3390/jcdd6020019 Saesarwati, D., & Satyabakti, P. (2017). Analisis Faktor Risiko Yang Dapat Dikendalikan Pada Kejadian Pjk Usia Produktif. Jurnal Promkes, 4(1), 22. https://doi.org/10.20473/jpk.v4.i1.2016.22-33 Sanchis-Gomar, F., Perez-Quilis, C., Leischik, R., & Lucia, A. (2016). Epidemiology of coronary heart disease and acute coronary syndrome. Annals of Translational Medicine, 4(13), 256–256. https://doi.org/10.21037/atm.2016.06.33 Saputri, S. W., Nugraha, A., Pratama, W., & Holidah, D. (2016). Studi Pengobatan Diabetes Melitus Tipe 2 dengan Komplikasi Hipertensi di Instalasi Rawat Jalan RSU dr. H. Koesnadi Bondowoso Periode Tahun 2014. E-Jurnal Pustaka Kesehatan, 4(3), 479–483. Scott, S. A., Owusu Obeng, A., & Hulot, J.-S. (2014). Antiplatelet drug interactions with proton pump inhibitors. Expert Opinion on Drug Metabolism & Toxicology, 10(2), 175–189. https://doi.org/10.1517/17425255.2014.856883 Shetty, V., Chowta, M. N., Chowta K, N., Shenoy, A., Kamath, A., & Kamath, P. (2018). Evaluation of Potential Drug-Drug Interactions with Medications Prescribed to Geriatric Patients in a Tertiary Care Hospital. Journal of Aging Research, 2018, 1–6. https://doi.org/10.1155/2018/5728957 Sinaga, F. A. (2010). Interaksi Farmakokinetika Pada Distribusi Obat. Jurnal Pengabdian Kepada Masyarakat, 16(60), 47-58. Srikandi, N., Mukaddas, A., & Faustine, I. (2017). Profil Penggunaan Obat Pada Pasien Dispepsia Di RSU Anutapura Palu. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)(e-Journal), 3(2), 126-131. Sulistiyowatiningsih, E., Hidayati, S. N., & Febrianti, Y. (2016). Kajian Potensi Interaksi Obat pada Pasien Gagal Jantung dengan Gangguan Fungsi Ginjal di Instalasi Rawat Inap RSUP DR. Sardjito Yogyakarta Periode 2009-2013. Jurnal Ilmiah Farmasi, 12(1), 25-33. Syukri, A. E. D. P. (2013). Profil Penyakit Jantung Koroner RSUP PROF. Dr. R. D. Kandou Manado. E-Clinic, 1(1), 1–8. https://doi.org/10.35790/ecl.1.1.2013.6036 Tajudin, T., Faradiba, V., Dwi, I., & Nugroho, W. (2019). Analisis Kombinasi Penggunaan Obat pada Pasien Jantung Koroner (Coronary Heart Disease) dengan Penyakit Penyerta di Rumah Sakit X Cilacap tahun 2019. In Jurnal Ilmiah Kefarmasian. http://e-jurnal.stikesalirsyadclp.ac.id/index.php/jp Tilson, H., Hines, L. E., McEvoy, G., Weinstein, D. M., Hansten, P. D., Matuszewski, K., le Comte, M., Higby-Baker, S., Hanlon, J. T., Pezzullo, L., Vieson, K., Helwig, A. L., Huang, S.-M., Perre, A., Bates, D. W., Poikonen, J., Wittie, M. A., Grizzle, A. J., Brown, M., & Malone, D. C. (2016). Recommendations for selecting drug–drug interactions for clinical decision support. American Journal of Health-System Pharmacy, 73(8), 576–585. https://doi.org/10.2146/ajhp150565 Totong, J., & Ningsih, D. W. (2020). Terapi Obat pada Pasien Diabetes Mellitus dengan Komplikasi di Rumah Sakit. Jurnal Ilmiah Kesehatan, 19(01), 38-44. Wahidah, W., & Harahap, R. A. (2021). [PJK)]: PJK (Penyakit Jantung Koroner) VS SKA (Sindrom Koroner Akut) Perspektif Epidemiologi. Afiasi: Jurnal Kesehatan Masyarakat, 6(1), 54-65. Wakabayashi, I. (2017). Gender differences in cardiovascular risk factors in patients with coronary artery disease and those with type 2 diabetes. Journal of Thoracic Disease, 9(5), E503–E506. https://doi.org/10.21037/jtd.2017.04.30 Weber, T., Lang, I., Zweiker, R., Horn, S., Wenzel, R. R., Watschinger, B., Slany, J., Eber, B., Roithinger, F. X., & Metzler, B. (2016). Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations. Wiener Klinische Wochenschrift, 128(13–14), 467–479. https://doi.org/10.1007/s00508-016-0998-5 WHO. World Health Statistic Report (2015). Geneva: World Health Organization; 2015 Wooten, J.M. 2012, Pharmacotherapy considerations in elderly adults. South Med J, Vol.105, No.8, pp.439 Yuliani, F., Oenzil, F., & Iryani, D. (2014). Hubungan Berbagai Faktor Risiko Terhadap Kejadian Penyakit Jantung Koroner Pada Penderita Diabetes Melitus Tipe 2. Jurnal Kesehatan Andalas, 3(1), 37–40. https://doi.org/10.25077/jka.v3i1.22 Zhao, Q., Wang, L., Kurlansky, P. A., Schein, J., Baser, O., & Berger, J. S. (2019). Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study. BMC Cardiovascular Disorders, 19(1), 19. https://doi.org/10.1186/s12872-018-0991- Zulkarni, R., Nessa, N., & Athifah, Y. (2019). Analisis Ketepatan Pemilihan dan Penentuan Regimen Obat pada Pasien Penyakit Paru Obstruktif Kronis (PPOK). Jurnal Sains Farmasi & Klinis, 6(2), 158-163 | id_ID |
